Prescriptions for opioids have increased 10-fold since 1990, and the United States has the highest rate of prescription opioid use per capita in the world, accounting for 80% of the world\'s opioid consumption.^[@R1],[@R2]^ Increased opioid prescriptions were accompanied by an increase in the incidence of opioid abuse, addiction, and overdose.^[@R3],[@R4]^ Although prescribing volume peaked in 2010, opioid use continues to be a major public health concern in the United States.^[@R4],[@R5]^

Physicians routinely prescribe opioids to patients to manage acute postoperative pain. There are an estimated 100 million operations done per year in the United States, with approximately 60% of those done in an ambulatory setting.^[@R6]^ Ninety-nine percent of patients who are hospitalized after undergoing a surgical procedure receive opioids,^[@R7]^ and 80% to 90% of patients undergoing outpatient surgery are sent home with an opioid prescription.^[@R8],[@R9]^ Both the proportion of patients receiving an opioid prescription and the total amount prescribed after low-risk outpatient surgery have increased since 2004.^[@R8]^ However, little is known about longer term patterns of postoperative opioid prescribing. In particular, opioid-prescribing changes associated with the approval and aggressive marketing of long-acting opioids such as OxyContin starting in the mid-1990s and the implementation of the Joint Commission\'s new hospital pain management standards in the early 2000s have not been described in the surgical cohort.^[@R10],[@R11]^ The destigmatization of opioid use and the widespread recognition of pain as a "fifth vital sign" that followed are credited with increasing physician acceptance of opioid prescribing in the United States during that time.^[@R12]^

We hypothesized that the total amount of opioids prescribed after surgery increased over time in parallel to the broader contextual changes in opioid prescribing in the United States. Using claims and prescribing data from a cohort of commercially insured patients, we studied postoperative opioid-prescribing patterns after selected common surgical procedures from 1994 to 2014. For each procedure type and year, we calculated the mean oral morphine milligram equivalents (MME) filled after surgery. We reported changes in overall patterns of postoperative opioid prescribing during the 21-year study period and identified predictors of filling a high-dose postoperative opioid prescription.

Methods {#s1}
=======

Study Oversight and Data Source {#s1-1}
-------------------------------

We studied a cohort of commercially insured enrollees from the OptumLabs Data Warehouse, a longitudinal, real-world data asset with more than 200 million deidentified lives across claims and clinical information.^[@R13]^ The claims data set includes inpatient and outpatient claims as well as pharmacy claims dating from 1993 to the present. Because we used deidentified administrative data, this study did not require institutional review board approval or waiver.

Study Cohort {#s1-2}
------------

Using Current Procedural Terminology (CPT) and *International Classification of Diseases, Ninth Revision* (*ICD-9*) diagnosis and procedure codes, we identified patients aged 18 years and older who underwent selected common surgical procedures between 1994 and 2014 and had at least 365 days of continuous enrollment before and 30 days of continuous enrollment after the date of surgery. These procedures were selected because they are common and because procedure-specific CPT and *ICD-9* codes were available throughout the 21-year study period. Table S1 in the Online Supplement, <http://links.lww.com/JG9/A60>, lists the CPT/*ICD-9* codes used to define our cohort. Patients with claims for two related procedures on the same day (eg, laparoscopic versus open cholecystectomy) were categorized with the more invasive procedure (ie, open cholecystectomy). Patients who underwent unrelated procedures from our list on the same day were excluded. We also excluded anyone with a hospital length of stay (LOS) over 14 days to account for unanticipated complications that could alter a patient\'s postoperative pain management needs. We extracted additional variables including pre-existing comorbidities, previous prescriptions, and surgery location for our analysis.

Predictor Variables {#s1-3}
-------------------

We tested the association between postoperative dose prescribed and patient, procedural, and geographic factors, as well as the year the surgery was done. Patient variables included patient demographics such as age, sex, and race; Deyo-Charlson Comorbidity Index; having pre-existing diagnoses associated with opioid use (chronic pain, anxiety, depression, psychosis, post-traumatic stress disorder, alcohol use, tobacco use, or substance abuse) or a current cancer diagnosis (Table S2, <http://links.lww.com/JG9/A60>); and previous pharmacy claims for medications including opioids, benzodiazepines, muscle relaxants, antidepressants, or antipsychotics. Diagnoses were considered if they were coded within 12 months of the date of surgery. To avoid overlap with the initial postoperative opioid prescription, all preoperative prescription claims (including all preoperative opioid prescriptions) were assessed starting from 12 months up to 30 days before the date of surgery. Procedure-related variables included procedure type, place of service, and hospital LOS for inpatient procedures. Outpatient procedures were designated as having a LOS of zero days.

Outcome Variable {#s1-4}
----------------

For each patient, we identified pharmacy claims for the index postoperative opioid prescription fill. Surgeons frequently provide opioid prescriptions to their patients ahead of scheduled surgery. Therefore, we defined the index postoperative opioid prescription fill as the first opioid prescription filled during a 14-day window comprising the 7 days before and after the date of surgery (outpatient procedures) or the date of discharge (inpatient procedures). Using Centers for Disease Control and Prevention (CDC) conversion factors (Table S3, <http://links.lww.com/JG9/A60>),^[@R14]^ we converted each unique opioid, dosage, and duration on the index prescription to its oral morphine equivalent dose in milligrams (MME). If patients filled more than one opioid on the date of the index prescription fill, the MME for each opioid was summed to calculate a total MME for the index prescription.

There are currently no nationally accepted guidelines for postoperative opioid prescribing. In this context, some investigators have used 200 MME as a threshold for excessive postoperative opioid prescribing.^[@R15]^ Other existing state and institutional guidelines recommend prescribing a maximum of 150 to 315 MME (∼20 to 42 tablets of oxycodone 5 mg) for most procedures included in our study.^[@R16][@R17][@R18]^ Given these guidelines, we adopted a total prescription dosage of ≥350 as a conservative definition of a high-dose postoperative opioid prescription fill.

Statistical Analysis {#s1-5}
--------------------

We evaluated prescriptions filled from 1994 to 2014. For each procedure and year, we calculated the mean and median postoperative MME filled. To account for the effect of the approval and marketing of long-acting opioids on opioid prescribing,^[@R10]^ we identified the proportion of patients whose index postoperative opioid prescription included a long-acting formulation and the proportion who had filled any preoperative prescription for long-acting opioids. We depicted changes in opioid selection over time. We used multiple logistic regression to assess the association of patient, surgery and geographic factors, year of surgery, and inclusion of long-acting opioids with the receipt of ≥350 MME on the index prescription. Wald chi-square tests were used to determine the statistical significance of these predictors.

Sensitivity Analysis {#s1-6}
--------------------

As a sensitivity analysis, we repeated our analyses in opioid-naive patients (patients without an opioid prescription fill starting from 12 months to 30 days before surgery).

All statistical analyses were done using R version 3.4.3 (The R Foundation).

Results {#s2}
=======

We identified 1,321,264 patients meeting inclusion criteria, of whom 1,061,104 (80.3%) filled an index postoperative opioid prescription (Table [1](#T1){ref-type="table"}). The mean age was 48.4 years (SD 12.9). Patients were predominantly female (58.9%), white (75.2%), and from the South (45.0%). Approximately 35.3% of patients received preoperative opioids, and 1.7% used long-acting opioids preoperatively. The mean and median index postoperative opioid prescription fill was 268.1 and 200 MME, respectively. Approximately 20.3% of patients received high-dose postoperative opioids (≥350 MME), and 1.8% filled a long-acting postoperative opioid prescription.

###### 

Baseline Characteristics for Patients Undergoing Selected Surgeries, 1994 to 2014

                                                                All Patients 1994-2014, N = 1,321,264   \%
  ------------------------------------------------------------- --------------------------------------- ------
  Patient characteristics                                                                               
   Age in years (SD)                                            48.4 (12.9)                             
   Sex                                                                                                  
    Male                                                        542,423                                 41.1
    Female                                                      778,841                                 58.9
   Race                                                                                                 
    White                                                       994,180                                 75.2
    Black                                                       86,679                                  6.6
    Asian                                                       22,394                                  1.7
    Hispanic                                                    91,217                                  6.9
    Unknown                                                     126,794                                 9.6
   Geographic region                                                                                    
    South                                                       594,124                                 45.0
    West                                                        178,110                                 13.5
    Midwest                                                     438,675                                 33.2
    Northeast                                                   110,355                                 8.4
   Deyo-Charlson Comorbidity Index                                                                      
    0-1                                                         1,130,752                               85.6
    2                                                           117,167                                 8.9
    3+                                                          73,345                                  5.6
   Active cancer diagnosis                                      14,518                                  1.1
   Predisposing factors                                                                                 
    Post-traumatic stress disorder                              4,694                                   0.4
    Anxiety                                                     101,287                                 7.7
    Depression                                                  143,673                                 10.9
    Psychosis                                                   5,038                                   0.4
    Chronic pain                                                16,249                                  1.2
    Substance abuse                                             10,054                                  0.8
    Tobacco use                                                 102,207                                 7.7
    Alcohol use                                                 13,285                                  1.0
   Prescriptions in previous 12 mo                                                                      
    Any opioid                                                  466,767                                 35.3
    Long-acting opioids                                         22,877                                  1.7
    Benzodiazepines                                             176,109                                 13.3
    Muscle relaxants                                            152,208                                 11.5
    Antidepressants                                             276,431                                 20.9
    Antipsychotics                                              6,706                                   0.5
  Surgical characteristics                                                                              
   Procedure type                                                                                       
    Arthroscopic knee meniscectomy                              242,605                                 18.4
    Laparoscopic cholecystectomy                                222,762                                 16.9
    Open hysterectomy                                           106,716                                 8.1
    Open inguinal hernia repair                                 101,756                                 7.7
    Carpal tunnel release                                       83,499                                  6.3
    Breast lumpectomy                                           73,967                                  5.6
    Laparoscopic appendectomy                                   69,773                                  5.3
    Total knee arthroplasty                                     68,333                                  5.2
    Lumbar laminectomy/laminotomy                               55,175                                  4.2
    Total hip arthroplasty                                      46,094                                  3.5
    Lap-assisted vaginal hysterectomy                           41,705                                  3.2
    Vaginal hysterectomy                                        38,051                                  2.9
    Open rotator cuff repair                                    34,610                                  2.6
    Open partial colectomy                                      33,600                                  2.5
    Laparoscopic inguinal hernia repair                         29,615                                  2.2
    Arthroscopic ACL repair                                     25,968                                  2.0
    Open appendectomy                                           18,646                                  1.4
    Simple mastectomy                                           16,232                                  1.2
    Open cholecystectomy                                        12,157                                  0.9
   Surgery location                                                                                     
    Hospital outpatient department                              612,675                                 46.4
    Inpatient hospital                                          493,900                                 37.4
    Ambulatory surgery center                                   207,922                                 15.7
    Office                                                      3,776                                   0.3
    Unknown                                                     2,991                                   0.2
   LOS in days                                                                                          
    0                                                           854,627                                 64.7
    1                                                           78,862                                  6.0
    2                                                           137,068                                 10.4
    3+                                                          250,707                                 19.0
   Year of surgery                                                                                      
    1994                                                        8,149                                   0.6
    1995                                                        9,336                                   0.7
    1996                                                        11,094                                  0.8
    1997                                                        13,894                                  1.1
    1998                                                        20,177                                  1.5
    1999                                                        29,511                                  2.2
    2000                                                        37,265                                  2.8
    2001                                                        40,660                                  3.1
    2002                                                        69,661                                  5.3
    2003                                                        84,413                                  6.4
    2004                                                        88,696                                  6.7
    2005                                                        88,027                                  6.7
    2006                                                        101,000                                 7.6
    2007                                                        100,491                                 7.6
    2008                                                        104,517                                 7.9
    2009                                                        99,772                                  7.6
    2010                                                        92,330                                  7.0
    2011                                                        88,620                                  6.7
    2012                                                        85,321                                  6.5
    2013                                                        80,042                                  6.1
    2014                                                        68,288                                  5.2
  Index prescription characteristics                                                                    
   Any opioid prescription                                      1,061,104                               80.3
   High-dose opioid prescription (≥350 MME)                     267,630                                 20.3
   Any long-acting opioid prescription                          23,401                                  1.8
   Mean postop MME prescribed (SD)                              268.1 (515.6)                           ---
   Median postop MME prescribed                                 200                                     ---
   Opioid class prescribed^[a](#tblfn1){ref-type="table-fn"}^                                           
    Hydrocodone_SA                                              528,446                                 49.8
    Oxycodone_SA                                                381,787                                 36.0
    Propoxyphene                                                81,072                                  7.6
    Codeine                                                     35,083                                  3.3
    Tramadol_SA                                                 20,635                                  1.9
    Oxycodone_LA                                                18,543                                  1.7
    Meperidine                                                  13,386                                  1.3
    Hydromorphone_SA                                            10,971                                  1.0
    Morphine_LA                                                 2,475                                   0.2
    Tapentadol_SA                                               1,561                                   0.1
    Fentanyl_LA                                                 1,457                                   0.1
    Pentazocine                                                 1,247                                   0.1
    Morphine_SA                                                 712                                     0.1
    Other                                                       1,549                                   0.1

ACL = anterior cruciate ligament, LA = long-acting, LOS = length of stay, MME = oral morphine milligram equivalents, SA = short-acting

Percentages represent proportion of all opioids prescribed.

The prevalence of postoperative opioid prescription fills increased from 67.7% of patients in 1994 to 82.8% in 2014 and was generally higher among patients undergoing orthopaedic procedures (Figure [1](#F1){ref-type="fig"}). The 2014 prevalence was highest for patients undergoing arthroscopic anterior cruciate ligament (ACL) repair (91.9%), open rotator cuff repair (90.6%), and lumbar laminectomy/laminotomy (85.8%). The mean and median postoperative MME filled each year for each procedure type also increased over time, particularly among patients undergoing orthopaedic procedures (Figure [2](#F2){ref-type="fig"}, Figures S1 and S2, <http://links.lww.com/JG9/A60>). Between 1994 and 2014, the mean postoperative MME filled increased by 145% for lumbar laminectomy/laminotomy, 84% for total knee arthroplasty, and 85% for total hip arthroplasty. All procedures showed a spike in prevalence of long-acting prescription fills in the year 2000 (prevalence ranged from 0.6% for breast lumpectomy to 6.7% for lumbar laminectomy/laminotomy); however, we found that the prescriptions filled by patients undergoing orthopaedic procedures had a sustained increase in the use of long-acting opioids (Figure [3](#F3){ref-type="fig"}A; Figure S3, <http://links.lww.com/JG9/A60>). By 2012, 11.1% of patients undergoing total knee arthroplasty, 8.9% undergoing total hip arthroplasty, and 8.6% undergoing lumbar laminectomy/laminotomy filled a long-acting opioid prescription. Preoperative use of long-acting opioids increased substantially during the study period, especially among patients undergoing lumbar laminectomy/laminotomy (Figure [3](#F3){ref-type="fig"}B; Figure S4, <http://links.lww.com/JG9/A60>). We found that patients who had previously been opioid-naive were also filling long-acting opioid prescriptions postoperatively (Figure [3](#F3){ref-type="fig"}C; Figure S5, <http://links.lww.com/JG9/A60>). Additional longitudinal trends in the opioid-naive cohort were consistent with our main findings (Figures S6 to S8, <http://links.lww.com/JG9/A60>).

![Percent of patients who filled an index postoperative opioid prescription, 1994 to 2014.](jg9-4-e19.00171-g001){#F1}

![Mean oral morphine equivalents prescribed on index postoperative opioid prescription fill, 1994 to 2014.](jg9-4-e19.00171-g002){#F2}

![**A**, Percent of patients with any long-acting opioid on index postoperative opioid prescription fill, 1994 to 2014. Denominator includes all patients in cohort, not just patients who filled an index postoperative opioid prescription. **B**, Percent of patients who filled any long-acting opioid prescription in the 12 months preceding surgery, 1994 to 2014. Preoperative long-acting opioid prescription claims were assessed starting from 12 months up to 30 days before the date of surgery. **C**, Percent of patients with any long-acting opioid on index postoperative opioid prescription fill, opioid-naive patients only, 1994 to 2014. Denominator includes all opioid-naive patients in cohort, not just patients who filled an index postoperative opioid prescription.](jg9-4-e19.00171-g003){#F3}

Prescribing of specific opioid medications changed over time (Figure S9, <http://links.lww.com/JG9/A60>). When looking at all procedures combined, hydrocodone and oxycodone were used in approximately 60% of postoperative opioid prescriptions filled in 1994, compared with 92% in 2014. The proportion of prescription fills that included codeine declined from 19% in 1994 to 3% in 2014. Propoxyphene declined from 21% in 1994 to 0% in 2011 after it was removed from the market in 2010 because of its association with fatal cardiac arrhythmias.^[@R19]^ After FDA approval in 1995, tramadol use increased to 5% in 2014, while long-acting oxycodone use increased to 2% in 2014. Similar changes in prescribing occurred in the opioid-naive cohort (Figure S10, <http://links.lww.com/JG9/A60>).

The likelihood of filling a high-dose postoperative opioid prescription was associated with patient-related variables such as younger age, white race, and the presence of predisposing diagnoses such as chronic pain Adjusted odds ratio (AOR) 1.35, 95% Confidence Interval (CI): 1.31, 1.40), substance abuse (AOR 1.07; 95% CI, 1.02, 1.13), and tobacco use (AOR 1.07; 95% CI, 1.05, 1.09) (Table [2](#T2){ref-type="table"}). Prescription drug use in the 12 months before surgery was also associated with a high-dose fill, including antidepressants (AOR 1.11, 95% CI, 1.10, 1.13), muscle relaxants (AOR 1.15, 95% CI, 1.13, 1.16), benzodiazepines (AOR 1.17, 95% CI, 1.15, 1.18), any opioid (AOR 1.27, 95% CI, 1.25, 1.28), and any long-acting opioid (AOR 1.30, 95% CI, 1.26, 1.35).

###### 

Predictors of Receiving High-Dose Opioids on Index Postoperative Opioid Prescription

                                                            Unadj. OR   (95% CI)         Adj. OR   (95% CI)         *P* (Wald test)
  --------------------------------------------------------- ----------- ---------------- --------- ---------------- -----------------
  Age (yr)                                                                                                          
   18-35 (ref)                                              ---         ---              ---       ---              ---
   35-45                                                    1.10        (1.09, 1.12)     1.01      (0.99, 1.03)     0.187
   45-55                                                    1.34        (1.32, 1.36)     0.99      (0.98, 1.01)     0.255
   55-65                                                    1.67        (1.65, 1.69)     0.92      (0.90, 0.93)     \<0.001
   65-75                                                    1.46        (1.43, 1.49)     0.67      (0.66, 0.69)     \<0.001
   75+                                                      0.97        (0.93, 1.00)     0.38      (0.37, 0.40)     \<0.001
  Sex                                                                                                               
   Male (ref)                                               ---         ---              ---       ---              ---
   Female                                                   0.87        (0.86, 0.88)     1.00      (0.99, 1.02)     0.479
  Race                                                                                                              
   White (ref)                                              ---         ---              ---       ---              ---
   Black                                                    0.90        (0.89, 0.92)     0.91      (0.90, 0.93)     \<0.001
   Asian                                                    0.74        (0.71, 0.77)     0.87      (0.83, 0.90)     \<0.001
   Hispanic                                                 0.79        (0.77, 0.80)     0.95      (0.93, 0.97)     \<0.001
   Unknown                                                  0.78        (0.77, 0.79)     0.96      (0.94, 0.98)     \<0.001
  Geographic region                                                                                                 
   South (ref)                                              ---         ---              ---       ---              ---
   West                                                     1.05        (1.04, 1.07)     0.95      (0.94, 0.97)     \<0.001
   Midwest                                                  0.96        (0.95, 0.97)     0.94      (0.93, 0.96)     \<0.001
   Northeast                                                0.71        (0.69, 0.72)     0.69      (0.68, 0.70)     \<0.001
  Deyo-Charlson Comorbidity Index                                                                                   
   0-1 (ref)                                                ---         ---              ---       ---              ---
   2                                                        1.04        (1.03, 1.06)     0.97      (0.96, 0.99)     0.003
   3+                                                       1.12        (1.10, 1.14)     1.00      (0.98, 1.03)     0.678
   Active cancer diagnosis                                  1.01        (0.97, 1.05)     0.97      (0.92, 1.01)     0.169
  Predisposing factors^[a](#tblfn2){ref-type="table-fn"}^                                                           
   Post-traumatic stress disorder                           1.31        (1.22, 1.40)     0.96      (0.89, 1.04)     0.328
   Anxiety                                                  1.20        (1.19, 1.22)     0.99      (0.97, 1.01)     0.273
   Chronic pain                                             3.28        (3.18, 3.38)     1.35      (1.30, 1.41)     \<0.001
   Substance abuse                                          1.91        (1.84, 2.00)     1.07      (1.02, 1.13)     0.008
   Tobacco use                                              1.30        (1.28, 1.32)     1.07      (1.05, 1.09)     \<0.001
   Alcohol use                                              1.32        (1.27, 1.38)     0.97      (0.93, 1.02)     0.268
  Prescriptions in previous 12 mo                                                                                   
   Any opioid                                               1.89        (1.87, 1.91)     1.27      (1.25, 1.28)     \<0.001
   Long-acting opioids                                      4.24        (4.13, 4.35)     1.30      (1.26, 1.35)     \<0.001
   Benzodiazepines                                          1.53        (1.51, 1.54)     1.17      (1.15, 1.18)     \<0.001
   Muscle relaxants                                         1.84        (1.82, 1.86)     1.15      (1.13, 1.16)     \<0.001
   Antidepressants                                          1.38        (1.37, 1.40)     1.11      (1.10, 1.13)     \<0.001
   Antipsychotics                                           1.72        (1.63, 1.81)     1.04      (0.98, 1.10)     0.220
  Procedure type                                                                                                    
   Laparoscopic cholecystectomy (ref)                       ---         ---              ---       ---              ---
   Lumbar laminectomy/laminotomy                            10.20       (9.98, 10.42)    7.55      (7.37, 7.74)     \<0.001
   Total hip arthroplasty                                   8.07        (7.89, 8.25)     6.72      (6.54, 6.91)     \<0.001
   Total knee arthroplasty                                  7.80        (7.65, 7.96)     6.64      (6.47, 6.81)     \<0.001
   Arthroscopic ACL repair                                  5.61        (5.45, 5.77)     5.44      (5.27, 5.60)     \<0.001
   Open rotator cuff repair                                 5.33        (5.20, 5.46)     5.20      (5.06, 5.35)     \<0.001
   Simple mastectomy                                        2.00        (1.92, 2.08)     1.78      (1.70, 1.86)     \<0.001
   Arthroscopic knee meniscectomy                           1.88        (1.85, 1.91)     2.10      (2.06, 2.14)     \<0.001
   Open cholecystectomy                                     1.81        (1.73, 1.90)     1.72      (1.63, 1.81)     \<0.001
   Carpal tunnel release                                    1.58        (1.54, 1.62)     1.67      (1.63, 1.71)     \<0.001
   Open partial colectomy                                   1.53        (1.48, 1.58)     1.50      (1.45, 1.56)     \<0.001
   Open hysterectomy                                        1.38        (1.35, 1.41)     1.20      (1.17, 1.23)     \<0.001
   Breast lumpectomy                                        1.25        (1.22, 1.28)     1.50      (1.46, 1.54)     \<0.001
   Lap-assisted vaginal hysterectomy                        1.16        (1.12, 1.20)     1.02      (0.99, 1.05)     0.288
   Vaginal hysterectomy                                     1.12        (1.08, 1.16)     1.02      (0.98, 1.05)     0.301
   Open inguinal hernia repair                              1.01        (0.98, 1.03)     1.21      (1.18, 1.24)     \<0.001
   Open appendectomy                                        0.98        (0.93, 1.03)     1.01      (0.96, 1.06)     0.835
   Laparoscopic inguinal hernia repair                      0.85        (0.82, 0.89)     0.96      (0.92, 1.00)     0.041
   Laparoscopic appendectomy                                0.75        (0.73, 0.77)     0.73      (0.71, 0.75)     \<0.001
  Surgery location                                                                                                  
   Hospital outpatient department (ref)                     ---         ---              ---       ---              ---
   Inpatient hospital                                       1.82        (1.80, 1.84)     0.91      (0.89, 0.94)     \<0.001
   Ambulatory surgery center                                1.19        (1.17, 1.20)     0.93      (0.92, 0.94)     \<0.001
   Office                                                   0.88        (0.81, 0.97)     0.82      (0.75, 0.90)     \<0.001
   Unknown                                                  1.22        (1.12, 1.34)     0.90      (0.81, 0.99)     0.033
  LOS                                                                                                               
   0 (ref)                                                  ---         ---              ---       ---              ---
   1                                                        1.19        (1.17, 1.21)     1.23      (1.20, 1.27)     \<0.001
   2                                                        1.61        (1.59, 1.63)     1.48      (1.44, 1.53)     \<0.001
   3+                                                       2.08        (2.06, 2.10)     1.27      (1.23, 1.30)     \<0.001
   Postop prescription included LA opioid                   70.94       (67.12, 74.99)   32.01     (30.23, 33.90)   \<0.001
  Year of surgery                                                                                                   
   1994 (ref)                                               ---         ---              ---       ---              ---
   1995                                                     0.98        (0.90, 1.07)     0.98      (0.89, 1.07)     0.617
   1996                                                     1.04        (0.96, 1.13)     1.01      (0.93, 1.10)     0.742
   1997                                                     1.07        (0.99, 1.16)     1.03      (0.95, 1.12)     0.432
   1998                                                     1.06        (0.99, 1.14)     1.00      (0.92, 1.08)     0.944
   1999                                                     1.14        (1.07, 1.23)     1.03      (0.96, 1.11)     0.444
   2000                                                     1.23        (1.15, 1.31)     1.05      (0.98, 1.13)     0.161
   2001                                                     1.34        (1.26, 1.44)     1.13      (1.06, 1.22)     \<0.001
   2002                                                     1.25        (1.17, 1.34)     1.03      (0.96, 1.11)     0.349
   2003                                                     1.33        (1.24, 1.41)     1.07      (1.00, 1.15)     0.052
   2004                                                     1.33        (1.25, 1.42)     1.07      (1.00, 1.14)     0.059
   2005                                                     1.39        (1.30, 1.48)     1.09      (1.02, 1.17)     0.011
   2006                                                     1.54        (1.45, 1.65)     1.21      (1.13, 1.30)     \<0.001
   2007                                                     1.60        (1.50, 1.71)     1.23      (1.15, 1.32)     \<0.001
   2008                                                     1.73        (1.62, 1.84)     1.32      (1.23, 1.41)     \<0.001
   2009                                                     1.79        (1.68, 1.91)     1.34      (1.26, 1.44)     \<0.001
   2010                                                     1.85        (1.74, 1.98)     1.39      (1.30, 1.49)     \<0.001
   2011                                                     1.62        (1.52, 1.73)     1.17      (1.10, 1.26)     \<0.001
   2012                                                     1.73        (1.62, 1.85)     1.25      (1.17, 1.34)     \<0.001
   2013                                                     1.80        (1.68, 1.92)     1.28      (1.19, 1.37)     \<0.001
   2014                                                     1.90        (1.78, 2.02)     1.37      (1.27, 1.46)     \<0.001

ACL = anterior cruciate ligament, LA = long-acting, LOS = length of stay, MME = oral morphine milligram equivalents, OR = odds ratio

Depression was removed as predictor variable because it was highly colinear with antidepressant use in the previous 12 months.

Patients who were discharged on postoperative day \#2 had higher adjusted odds of filling a high-dose postoperative opioid prescription (1.48, 95% CI, 1.44, 1.53), compared with patients with shorter or longer hospitalizations or having ambulatory surgery. Year of surgery from the early 2000s through 2014 was also associated with higher adjusted odds of having a high-dose postoperative prescription fill. The procedures with the highest adjusted odds of patients filling a high-dose postoperative opioid prescription were all orthopaedic procedures: lumbar laminectomy/laminotomy (7.55, 95% CI, 7.37, 7.74), total hip arthroplasty (6.72, 95% CI, 6.54, 6.91), total knee arthroplasty (6.64, 95% CI, 6.47, 6.81), arthroscopic anterior cruciate ligament repair (5.44, 95% CI, 5.27, 5.60), and open rotator cuff repair (5.20, 95% CI, 5.06, 5.35). Patients whose postoperative opioid prescription included a long-acting formulation had the highest adjusted odds of filling a high-dose prescription (AOR 32.01, 95% CI, 30.23, 33.90).

In a sensitivity analysis limited to opioid-naive patients (Table S4, <http://links.lww.com/JG9/A60>), procedure type and use of a long-acting formulation in the postoperative prescription remained the strongest predictors for filling a high-dose postoperative opioid prescription (Table S5, <http://links.lww.com/JG9/A60>).

Discussion {#s3}
==========

In this study of long-term postoperative opioid-prescribing trends in commercially insured patients, we found that changes in the characteristics of the index postoperative opioid prescription filled by adult patients undergoing common surgical procedures mirrored the broader increase in opioid prescribing in the United States.^[@R1],[@R2]^ Postoperative opioid prescription fills increased in both prevalence and total MME prescribed, and---after new long-acting opioids such as OxyContin became widely marketed---in the likelihood that a long-acting formulation was included.

The increase in the prevalence and dose of postoperative opioids is notable because it occurred despite improvements in both surgical technique and perioperative pain management approaches during the same period. The use of minimally invasive approaches, advances in neuraxial and regional anesthetic techniques, and the introduction of enhanced recovery pathways and multimodal analgesic approaches for many of these procedures should have decreased patients\' postoperative pain and the opioid dosage on the index prescription that would have been expected to meet their needs.^[@R20][@R21][@R22][@R23]^ However, these perioperative advances coincided with the introduction and marketing of OxyContin and other long-acting opioids in the mid-1990s,^[@R10],[@R24]^ the simultaneous liberalization of what were considered to be appropriate indications for receiving a new opioid prescription,^[@R25]^ and the implementation of the Joint Commission standards for the evaluation and treatment of pain among hospitalized patients in the early 2000s.^[@R12],[@R26]^ Others have noted that the increased likelihood of preexisting opioid tolerance and the trend toward same-day surgeries and earlier discharge after inpatient surgery also may have contributed to escalating opioid dosages, compared with an earlier epoch when more patients would have been opioid-naive before surgery and would have had longer inpatient stays after surgery.^[@R1],[@R12],[@R26]^ In addition, pharmaceutical manufacturers may have targeted marketing to certain physicians preferentially based on their specialty.^[@R10],[@R20],[@R24],[@R27]^

These broader influences on postoperative opioid prescribing are illustrated by our study results, particularly among patients undergoing orthopaedic surgery. The strongest predictor of receiving a high-dose opioid prescription in our study was whether the prescription included a long-acting opioid, followed closely by whether patients were undergoing one of several common orthopaedic procedures. Our study does not specifically address the factors that may have led to the more frequent reliance on long-acting opioids in orthopaedic surgery patients postoperatively compared with patients undergoing nonorthopaedic procedures. Notably, most of the orthopaedic procedures included in our study are indicated to treat chronic musculoskeletal pain, which makes it more likely that these patients were already receiving opioids preoperatively. This is evidenced by the longitudinal increase in prevalence of long-acting opioids, especially among patients undergoing lumbar laminectomy/laminotomy.

However, our results among opioid-naive patients showed similar increases in MMEs prescribed over time. Consistent with our findings in the overall cohort, the inclusion of a long-acting formulation and undergoing the same orthopaedic procedures were the strongest predictors of filling a high-dose prescription in the opioid-naive cohort as well. Others have reported on the inclusion of OxyContin in orthopaedic clinical pathways to facilitate earlier hospital discharge, which may be contributing to the greater prescription dosages in these patients.^[@R20],[@R27]^ These results suggest that postoperative opioid-prescribing practice changes over time were not driven solely by patients\' preoperative opioid use.

The use of OxyContin in the postoperative setting continued despite changes in the labeling of OxyContin in July 2001 that specified it should not be used to treat pain in the immediate postoperative period.^[@R28]^ Others have shown that the initiation of postoperative opioids in previously opioid-naive patients is associated with increased risk of chronic use,^[@R29],[@R30]^ and introducing long-acting opioids to opioid-naive patients is associated with increased all-cause mortality.^[@R31]^ For many patients, surgery is the instigating event for first opioid use; therefore, surgeons have a particular responsibility to avoid the inappropriate use of long-acting opioids.^[@R32],[@R33]^

Our study has several limitations. First, there were changes to the OptumLabs data set over the 21-year study period, including changes in number of covered lives and case mix represented. Second, we studied selected surgical procedures in a commercially insured cohort, which may limit the generalizability of our findings to patients undergoing other procedures or who are not commercially insured. Other limitations related to the use of administrative claims data also apply. Third, some of the index prescriptions filled within our designated 14-day prescribing window may have been provided for indications unrelated to surgery. Furthermore, the prescriptions we analyzed only included those that were filled and submitted to insurance. Therefore, the exclusion of written but unfilled opioid prescriptions could have affected our results, since patients who fill opioid prescriptions after surgery may differ from patients who receive an opioid prescription but do not fill it. Fourth, the goal of this study was to understand long-term postoperative opioid-prescribing trends reflected by the index postoperative opioid prescription during the years immediately after the introduction of new long-acting opioids such as OxyContin through the peak of the prescription opioid epidemic; postoperative opioid-prescribing practices may have changed since 2014. Finally, our high-dose prescription threshold of 350 MME may not be the optimal threshold for all types of surgical pain, especially for more invasive procedures such as total knee arthroplasty. However, since there are currently no nationally accepted standards for postoperative opioid prescribing in the surgical cohort, our designation of 350 MME as a threshold for high-dose prescribing provides a starting point for further discussion.

In summary, we found that postoperative opioid prescribing in commercially insured patients increased in parallel with broader US opioid-prescribing trends since the mid-1990s, especially among patients undergoing orthopaedic surgical procedures. The increase in the mean annual MME filled starting in the late 1990s was driven in part by the higher proportion of long-acting opioid formulations on the index postoperative opioid prescription filled by orthopaedic surgery patients. Understanding the factors that contribute to high-dose opioid prescribing after surgery is critical to maximizing the benefits of opioid therapy while avoiding opioid-associated adverse events. Surgeons should continue to limit the use of long-acting opioids in the immediate postoperative setting as a way to reduce high-dose prescription fills in patients undergoing orthopaedic surgical procedures.
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